Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-03

FDA Approved: SYMDEKO — Supplemental Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

FDA approved a supplemental application for Symdeko (tezacaftor and ivacaftor) from Vertex Pharmaceuticals Incorporated. The action relates to an update to the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symdeko (tezacaftor/ivacaftor)

Snippet

SUPPL AP for SYMDEKO (TEZACAFTOR AND IVACAFTOR)